Daniel R. Passeri
President and Chief Executive Officer

Michael P. Gray
Chief Operating and Chief Financial Officer

Changgeng Qian, Ph.D., M.D.
Senior Vice President, Discovery and Preclinical Development

Mark Noel
Vice President, Technology Management and Intellectual Property

Mitchell Keegan
Vice President, Drug Development